You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Lignes directrices et conseils

À propos des lignes directrices

Displaying Guidelines

6 articles

Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non–Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update

Document Status: Archived
ID: GL-7-A-2016-3

Apr 2017

Guidance on the Substitution of Systemic Therapy Agents

Document Status: Current
ID: GL-C50-33
Version: 1

Aug 2017

Management of Primary Central Nervous System Diffuse Large B-Cell Lymphoma

Document Status: Current
ID: GL SCT-8

Oct 2017

Recommendations for the Safe Use and Handling of Oral Anti-Cancer Drugs (OACDs) in Community Pharmacy: A Pan-Canadian Consensus Guideline

Document Status: Current
ID: GL-C50-30

Feb 2017

Systemic Therapy for Recurrent Epithelial Ovarian Cancer

Document Status: Current
ID: 4-3
Version: 4

Jul 2017

Use of Preoperative Chemotherapy With or Without Postoperative Radiotherapy in Technically Resectable Stage IIIA Non-Small Cell Lung Cancer

Document Status: Archived
ID: 7-4
Version: 2

Dec 2017